Clinical Trials Browser

Phase 1/2 × OTHER × Advanced BRAF Mutant Cancers × Clear all

NCT03843775 2024-10-21

A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Phase 1/2 Completed

17 enrolled 9 charts

Advanced BRAF Mutant Cancers